clearbridge health
Clearbridge Health raises S$1.98 million in placement backed by Azure Capital
The placement of 990 million shares, at S$0.002 each, has been fully taken up
Clearbridge Health sees ‘material decrease’ in FY2023 results; expects impairment, fair value losses
CLEARBRIDGE Health has recorded a “material decrease” in its FY2023 financial performance amid lower revenues from several business segments, the Catalist-listed company announced on Friday (Feb 9).
Clearbridge mulls Biolidics’ request for more time to repay S$2.1 million debt
CLEARBRIDGE Health is considering Biolidics’ proposal to repay its debt, which amounts to some S$2.1 million, by the extended deadline of Dec 23, 2023.
Lawsuit against Clearbridge CEO, former unit in Jakarta withdrawn
A CIVIL lawsuit in Indonesia against Clearbridge Health chief executive Jeremy Yee and the company’s former subsidiary Indo Genesis Medika (IGM) has been withdrawn.
Lawsuit filed against Clearbridge Health chief in Jakarta court
MEDICAL tech company Clearbridge Health’s executive director and chief executive Jeremy Yee is among the defendants named in a civil suit filed by the shareholder of a former subsidiary, the company s...
Clearbridge proposes new business unit to invest in and grow healthcare firms
PRECISION medicine firm Clearbridge Health is looking to enter the business of investing in and divesting healthcare companies.
Clearbridge Health receives second batch of Sinopharm Covid-19 vaccines in Singapore
CLEARBRIDGE Health on Wednesday said its second batch of Sinopharm Covid-19 vaccines have arrived in Singapore.
Hot stock: Clearbridge Health up 10.5%; unit to supply Sinopharm Covid-19 vaccine for use in Singapore
SHARES of Clearbridge Health are up in early trade on Tuesday, after it said on Monday that its subsidiary has entered into a contract to purchase the Sinopharm Covid-19 vaccine directly from its manu...
Clearbridge unit to purchase Sinopharm Covid-19 vaccine for use in Singapore
CATALIST-LISTED Clearbridge Health said on Monday that its subsidiary has entered into a contract to purchase the Sinopharm Covid-19 vaccine directly from its manufacturer.
Lawsuit against two Clearbridge units dismissed over jurisdiction issue
A LAWSUIT filed by a joint venture partner of a ClearBridge Health unit has been dismissed by an Indonesian court due to a jurisdiction issue, the Catalist-listed company announced in a Tuesday bourse...
